https://orcid.org/0000-0002-4450-0280
References
- Candel FJ, Borges Sá M, Belda S, et al. Current aspects in sepsis approach. Turning things around. Rev Esp Quimioter. 2018;31:298–315. doi:10.1097/EJA.0000000000000798
- Evans L, Rhodes A, Alhazzani W, et al. Executive summary: surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock 2021. Crit Care Med. 2021;49:1974–1982. doi:10.1097/CCM.0000000000005357
- The Eight Societies Joint Committee for enhancement of antimicrobial stewardship. Guidance for implementing an antimicrobial stewardship program in Japan. Jpn J Chemother. 2017;65:650–687. Japanese.
- Yan Y, Tomooka K, Naito T, Tanigawa T. Decreased number of inpatients with community-acquired pneumonia during the COVID-19 pandemic: a large multicenter study in Japan. J Infect Chemother. 2022;28:709–713. doi:10.1016/j.jiac.2022.01.013
- Miyagami T, Uehara Y, Harada T, et al. Delayed treatment of bacteremia during the COVID-19 pandemic. Diagnosis. 2021;19:327–332. doi:10.1515/dx-2020-0114
- Nadia A, Erick O, Patricia MS, et al. Prehospital antibiotics in the ambulance for sepsis: a multicentre, open label, randomised trial. Lancet Respir Med. 2018;6:40–50. doi:10.1016/S2213-2600(17)30469-1
- Sasano H, Yoshizawa T, Kawakami T, et al. Improvements in quality indicators for the treatment of infectious diseases with intervention by an antimicrobial stewardship team. J Hosp Gen Med. 2021;3:1–10.
- Mormeneo BS, Palacián RMP, Moreno HM, Villuendas UMC. Bacteremia during COVID-19 pandemic in a tertiary hospital in Spain. Enferm Infecc Microbiol Clin. 2022;40:183–186. doi:10.1016/j.eimc.2021.01.015
- Matthew PC, Robert S, Katryn P, et al. Blood culture results before and after antimicrobial administration in patients with severe manifestations of sepsis: a diagnostic study. Ann Intern Med. 2019;171:547–554. doi:10.7326/M19-1696
- Papadimitriou-Olivgeris M, Psychogiou R, Garessus J, et al. Predictors of mortality of bloodstream infections among internal medicine patients in a Swiss hospital: role of quick sequential organ failure assessment. Eur J Intern Med. 2019;65:86–92. doi:10.1016/j.ejim.2019.05.003
- Rüddel H, Thomas-Rüddel DO, Reinhart K, et al. Adverse effects of delayed antimicrobial treatment and surgical source control in adults with sepsis: results of a planned secondary analysis of a cluster-randomized controlled trial. Crit Care. 2022;26:51. doi:10.1186/s13054-022-03901-9
- Seymour CW, Liu VX, Iwashyna TJ, et al. Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):762–774. doi:10.1001/jama.2016.0288
- Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41:580–637. doi:10.1097/CCM.0b013e31827e83af
- Abe T, Ogura H, Shiraishi A, et al. Characteristics, management, and in-hospital mortality among patients with severe sepsis in intensive care units in Japan: the FORECAST study. Crit Care. 2018;22:322. doi:10.1186/s13054-018-2186-7
- van den Bosch CM, Hulscher ME, Natsch S, et al. Development of quality indicators for antimicrobial treatment in adults with sepsis. BMC Infect Dis. 2014;14:345. doi:10.1186/1471-2334-14-345
- Lawrence M, Olesen F. Indicators of quality in health care. Eur J Gen Pract. 1997;3:103–108. doi:10.3109/13814789709160336
- Harada T, Watari T, Miyagami T, Watanuki S, Shimzu T, Hiroshige J. COVID blindness: delayed diagnosis of aseptic meningitis in the COVID-19 era. Eur J Case Rep Intern Med. 2020;7:001940. doi:10.12890/2020_001940
- Abe T, Kushimoto S, Tokuda Y, et al. Implementation of earlier antibiotic administration in patients with severe sepsis and septic shock in Japan: a descriptive analysis of a prospective observational study. Crit Care. 2019;23:360. doi:10.1186/s13054-019-2644-x